A Prospective Multicenter Luminex-Based Clinical Algorithm to Define Unacceptable HLA Mismatches Before Kidney Transplantation. Consequences on Outcome, Waiting Time, and Wait List Composition
Transplant International · 2026
DOI: 10.3389/ti.2025.15497 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Transplant International, 2026. Verfasst von Fabian Köppen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, Regensburg University Hospital, Regensburg, Germany. Hauptthemen laut MEDLINE: Kidney Transplantation, Waiting Lists, HLA Antigens, Histocompatibility Testing. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Determination of unacceptable human leukocyte antigen (HLA) mismatches (UAM) before kidney transplantation (KT) aims at minimizing immunological risk and routinely involves Luminex single antigen bead (SAB) testing. SAB-UAM criteria, however, often lack standardization. We implemented standardized mean fluorescence intensity (MFI)-based SAB-UAM criteria in four German transplant centers and prospectively studied the consequences on waitlist composition as well as waiting time, early antibody-mediated rejection (AMR) and graft loss in 267 patients. HLA were deemed unacceptable in case of CDC-reactivity or antibodies against known HLA from previous transplants irrespective of MFI. For all other antibodies, the MFI cut-off was 5.000 with the exception of 10.000 for anti-HLA DQ. We observed significant accumulation of highly sensitized patients (virtual panel-reactivity >95%) on the waiting list during the study period. Median time to KT was longer in patients with UAM, but differences were not statistically significant. Patients with preformed donor-specific anti-HLA antibodies (DSA) below the UAM cut-off criteria (39/267) experienced more AMR episodes compared to DSA-negative patients (10.3% vs. 1.3%, p < 0.001). Graft survival, however, was not statistically different over a median follow-up of four years. Standardized SAB-UAM criteria associated with good short-term outcomes but resulted in accumulation of highly sensitized patients on the waiting list.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nephrology, Regensburg University Hospital, Regensburg, Germany.
- Department of General, Visceral and Transplantation Surgery, University Medical Center, Mainz, Germany.
- Department of Internal Medicine, University of Würzburg, Würzburg, Germany.
- Department of Nephrology and Hypertension, University Hospital Erlangen, Erlangen, Germany.
- Department of Internal Medicine 5-Hematology and Oncology, University Hospital Erlangen, Erlangen, Germany.
- Department of Nephropathology, Institute of Pathology, University of Erlangen-Nürnberg, Erlangen, Germany.
Zitieren
APA
Köppen, F., Koch, M., Lopau, K., Heller, K., Luber, M., Spriewald, B., Amann, K., Jung, A., Weinmann-Menke, J., Drasch, T., Werner, J., Banas, B., & Zecher, D. (2026). A Prospective Multicenter Luminex-Based Clinical Algorithm to Define Unacceptable HLA Mismatches Before Kidney Transplantation. Consequences on Outcome, Waiting Time, and Wait List Composition. Transplant International. https://doi.org/10.3389/ti.2025.15497
Vancouver
Köppen F, Koch M, Lopau K, Heller K, Luber M, Spriewald B, et al. A Prospective Multicenter Luminex-Based Clinical Algorithm to Define Unacceptable HLA Mismatches Before Kidney Transplantation. Consequences on Outcome, Waiting Time, and Wait List Composition. Transplant International. 2026. doi:10.3389/ti.2025.15497
BibTeX
@article{Kppen2026,
author = {Köppen, Fabian and Koch, Martina and Lopau, Kai and Heller, Katharina and Luber, Markus and Spriewald, Bernd and Amann, Kerstin and Jung, Achim and Weinmann-Menke, Julia and Drasch, Thomas and Werner, Jens and Banas, Bernhard and Zecher, Daniel},
title = {A Prospective Multicenter Luminex-Based Clinical Algorithm to Define Unacceptable HLA Mismatches Before Kidney Transplantation. Consequences on Outcome, Waiting Time, and Wait List Composition},
journal = {Transplant International},
year = {2026},
doi = {10.3389/ti.2025.15497}
}
EUVIMED